In healthy immunocompetent women, how long does human papillomavirus type 18 or 45 remain detectable in the cervix?

Duration of HPV 18/45 Cervical Infection

In healthy immunocompetent women, most HPV 18 and 45 infections become undetectable within 1-2 years, with approximately 90% clearing spontaneously without intervention. 1

Natural Clearance Timeline

The evidence consistently demonstrates that HPV infections, including high-risk types 18 and 45, follow a predictable clearance pattern:

• Most infections (approximately 90%) become undetectable within 1-2 years of initial detection through immune-mediated clearance 1, 2
• The immune system clears HPV infection most of the time in healthy individuals, though in some persons HPV infection does not resolve 3
• Clearance rates are highest in younger women, with women under 30 years showing approximately 60% regression rates even for established CIN2 lesions 4

Age-Related Differences in Persistence

The duration HPV remains detectable varies significantly by age:

• Women under 30 years: HPV infection rates can be as high as 43%, but the overwhelming majority of these infections resolve spontaneously, including those due to high-risk genotypes like HPV 18 and 45 5
• Women over 30 years: Persistent infections are more common, and women with HPV positivity in this age group have higher risk of persistent disease 6
• Following rapid accumulation of incident infections after onset of sexual activity (women <20 years), there is a transition favoring virus clearance soon after age 25 7

What "Persistence" Actually Means

Persistent infection is typically defined as the same HPV type remaining detectable for more than 12-24 months 1, 4:

• One-year and two-year HPV persistence, especially by HPV 16 (though similar principles apply to HPV 18 and 45), strongly predict progression to high-grade lesions 1
• Women whose infections persist beyond 1-2 years are at significant risk of developing precancerous lesions 1
• The longer an HPV infection persists, the less likely a patient is to clear the infection 2

Clinical Implications for HPV 18 and 45 Specifically

While HPV 16 is most studied, HPV 18 and 45 have distinct characteristics:

• HPV 18 accounts for 10-15% of cervical cancers and causes a greater proportion of glandular cancers (adenocarcinoma) compared to squamous cell carcinoma (approximately 32% vs. 8%) 1
• HPV types 16,18, and 45 together account for 85.7% of CIN 2-3 lesions that progress, with 88.2% of CIN 3 lesions being positive for one or more of these types 8
• Detection of high-risk HPV infection does not indicate when the infection was acquired, and HPV infection can be present for many years before it is detected 3

Important Caveats

The stepwise development from HPV acquisition to invasive cancer takes an average of 20 years, with the longest interval being from high-grade lesions to invasive cancer 2:

• This prolonged timeline reflects the time needed for random genetic events and viral integration 2
• However, some cases can develop more rapidly than the average 2
• Re-appearance of the same HPV type after documented clearance is rare (only 3.7% showed definite clearance and re-appearance), and progression to CIN2+ after re-appearance is extremely uncommon 9

Postmenopausal Considerations

A notable exception to typical clearance patterns occurs at postmenopause:

• Failure to eradicate the virus at postmenopause is not uncommon, explaining a second peak in HPV prevalence in many populations 7
• The mechanisms making some women over 55 years unable to clear infections that younger women typically clear remain incompletely understood 7